Preserved and stable compositions containing peptide copper complexes and method related thereto
View Patent ↗Compositions comprising at least one peptide copper complex and at least one preservative exhibit chemical stability of the peptide copper complex, as well as resistance and/or toxicity to microbial growth, when the preservative is selected to be a non-formaldehyde-donating preservative. In other embodiments, the present invention is directed to such compositions that are formulated for use as pharmaceuticals and cosmetic products, and to medical devices comprising a disclosed composition. In another aspect, the present invention is also directed to a method for imparting to a composition comprising at least one peptide copper complex, chemical stability as well as resistance and/or toxicity to microbial growth, where the method comprises incorporating a non-formaldehyde-donating preservative in the composition.
1. A preserved and chemically stable composition comprising at least one peptide copper complex and a preservative, wherein the preservative consists essentially of at least one non-formaldehyde-donating preservative, and wherein the at least one non-formaldehyde-donating preservative is selected from the group consisting of ammonium benzoate, ammonium propionate, benzisothiazolinone, benzoic acid, benzotriazole, benzylparaben, 5-bromo-5-nitro-1,3-dioxane, 2-bromo-2-nitropropane-1,3-diol, butyl benzoate, calcium benzoate, calcium paraben, calcium propionate, calcium salicylate, calcium sorbate, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, chloroacetamide, chlorobutanol, p-chloro-m-cresol, chlorophene, p-chlorophenol, chlorophenesin, chlorothymol, chloroxylenol, m-cresol, o-cresol, p-cresol, dehydroacetic acid, dibromopropamidine diisethionate, dimethyl oxazolidine, dithiomethylbenzamide, domiphen bromide, ethyl ferulate, ferulic acid, glyoxal, hexamidine, hexamidine diparaben, hexamidine paraben, 4-hydroxybenzoic acid, hydroxymethyl dioxoazabicyclooctane, iodopropynyl butylcarbamate, isodecylparaben, isopropyl cresols, isopropyl sorbate, lauryl diethylenediaminoglycine HCl, magnesium benzoate, magnesium propionate, MEA-benzoate, MEA o-phenylphenate, methyl-chloroisothiazolinone, methyl-dibromo methylisothiazolinone, octylisothiazolinone, panthenyl ethyl ether benzoate, phenethyl alcohol, phenol, phenoxyethylparaben, phenoxyisopropanol, phenyl benzoate, phenylparaben, o-phenylphenol, polymethoxy bicyclic oxazolidine, potassium benzoate, potassium butylparaben, potassium ethylparaben, potassium methylparaben, potassium paraben, potassium phenoxide, potassium o-phenylphenate, potassium propionate, potassium propylparaben, potassium sorbate, propionic acid, propyl benzoate, quaternium-8, quaternium-14, quaternium-15, sodium benzoate, sodium butylparaben, sodium p-chloro-m-cresol, sodium dehydroacetate, sodium ethylparaben, sodium formate, sodium hydroxymethane sulfonate, sodium hydroxymethylglycinate, sodium isobutylparaben, sodium isopropylparaben, sodium lauryl diethylenediaminoglycinate, sodium methylparaben, sodium paraben, sodium phenolsulfonate, sodium phenoxide, sodium o-phenylphenate, sodium propionate, sodium propylparaben, sodium sorbate, sorbic acid, triethanolamine sorbate, thianthol, triclocarban, triclosan, and undecylenoyl PEG-5paraben.
2. The composition of claim 1 wherein the at least one peptide copper complex is present at a concentration ranging from about 0.05% to about 25% by weight of the composition.
3. The composition of claim 1 wherein the at least one peptide copper complex is present at a concentration ranging from about 0.05% to about 2% by weight of the composition.
4. The composition of claim 1 wherein the at least one peptide copper complex is present at a concentration ranging from about 0.1% to about 0.5% by weight of the composition.
5. The composition of claim 1 wherein the molar ratio of peptide to copper in the at least one peptide copper complex ranges from about 1:1 to about 3:1.
6. The composition of claim 1 wherein the at least one peptide copper complex is glycyl-L-histidyl-L-lysine:copper(II).
7. The composition of claim 1 wherein the at least one peptide copper complex is L-alanyl-L-histidyl-L-lysine:copper(II).
8. The composition of claim 1 wherein the at least one peptide copper complex is L-valyl-L-histidyl-L-lysine:copper(II).
9. The composition of claim 1 wherein the at least one peptide copper complex is composed of a peptide or mixture of peptides formed by the hydrolysis of naturally occurring proteins, polypeptides, and larger peptides of either plant, microbial, or animal origin.
10. The composition of claim 1 wherein the composition is an aqueous solution having a pH adjusted to from about 4.5 to about 7.5.
11. The composition of claim 1 wherein the composition further comprises propylene glycol.
12. The composition of claim 1 wherein the at least one peptide copper complex is encapsulated in a liposome or microsponge adapted to aid in the delivery of the peptide copper complex, or to enhance the stability of the composition.
13. The composition of claim 1 wherein the at least one peptide copper complex is formulated in an instrument adapted to deliver the peptide copper complex via iontophoresis or ultrasound.
14. The composition of claim 1 , further comprising an inert and physiologically-acceptable carrier or diluent.
15. The composition of claim 14 wherein the inert and physiologically-acceptable carrier or diluent is water, physiological saline, bacteriostatic saline, a petrolatum based cream, a pharmaceutically acceptable gel, a short chain alcohol, or a short chain glycol.
16. The composition of claim 1 wherein the composition is a complex pharmaceutical or cosmetic formulation comprising a gel, cream, lotion, serum, or milk.
17. The composition of claim 1 , further comprising a sunscreen agent, a skin conditioning agent, a tanning agent, a skin protectant, an emollient, or a humectant.
18. The composition of claim 1 , further comprising a fatty alcohol, a fatty acid, an organic base, an inorganic base, a preserving agent, a wax ester, a steroid alcohol, a triglyceride ester, a phospholipid, a polyhydric alcohol ester, a fatty alcohol ether, a hydrophilic lanolin derivative, a hydrophilic beeswax derivative, a cocoa butter wax, a silicon oil, a pH balancer, a cellulose derivative, a hydrocarbon oil, or a mixture thereof.
19. The composition of claim 1 , further comprising an emulsifying agent, a surfactant, a thickening agent, an excipient, or a mixture thereof.
20. The composition of claim 1 wherein the composition is in the form of a liquid, lotion, cream, gel, emulsion, or microemulsion.
21. The composition of claim 1 , further comprising an active drug substance.
22. The composition of claim 1 , further comprising an active cosmetic substance.
23. The composition of claim 1 , further comprising an active cosmetic substance where the active cosmetic substance is retinol, retinoic acid, or derivatives thereof.
24. The composition of claim 1 , further comprising an active cosmetic substance where the active cosmetic substance is a phytochemical.
25. A medical device comprising the composition of claim 1 .
26. A method for inhibiting microbial growth or reducing microbe populations in a composition comprising at least one peptide copper complex, while also substantially preserving the chemical stability of the at least one peptide copper complex, wherein the method comprises incorporating a preservative into the composition, wherein the preservative consists essentially of at least one non-formaldehyde-donating preservative, and wherein the at least one non-formaldehyde-donating preservative is selected from the group consisting of ammonium benzoate, ammonium propionate, benzisothiazolinone, benzoic acid, benzotriazole, benzylparaben, 5-bromo-5-nitro-1,3-dioxane, 2-bromo-2-nitropropane-1,3-diol, butyl benzoate, calcium benzoate, calcium paraben, calcium propionate, calcium salicylate, calcium sorbate, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, chloroacetamide, chlorobutanol, p-chloro-m-cresol, chlorophene, p-chlorophenol, chlorophenesin, chlorothymol, chloroxylenol, m-cresol, o-cresol, p-cresol, dehydroacetic acid, dibromopropamidine diisethionate, dimethyl oxazolidine, dithiomethylbenzamide, domiphen bromide, ethyl ferulate, ferulic acid, glyoxal, hexamidine, hexamidine diparaben, hexamidine paraben, 4-hydroxybenzoic acid, hydroxymethyl dioxoazabicyclooctane, iodopropynyl butylcarbamate, isodecylparaben, isopropyl cresols, isopropyl sorbate, lauryl diethylenediaminoglycine HCl, magnesium benzoate, magnesium propionate, MEA-benzoate, MEA o-phenylphenate, methyl-chloroisothiazolinone, methyl-dibromo methylisothiazolinone, octylisothiazolinone, panthenyl ethyl ether benzoate, phenethyl alcohol, phenol, phenoxyethylparaben, phenoxyisopropanol, phenyl benzoate, phenylparaben, o-phenylphenol, polymethoxy bicyclic oxazolidine, potassium benzoate, potassium butylparaben, potassium ethylparaben, potassium methylparaben, potassium paraben, potassium phenoxide, potassium o-phenylphenate, potassium propionate, potassium propylparaben, potassium sorbate, propionic acid, propyl benzoate, quaternium-8, quaternium-14, quaternium-15, sodium benzoate, sodium butylparaben, sodium p-chloro-m-cresol, sodium dehydroacetate, sodium ethylparaben, sodium formate, sodium hydroxymethane sulfonate, sodium hydroxymethylglycinate, sodium isobutylparaben, sodium isopropylparaben, sodium lauryl diethylenediaminoglycinate, sodium methylparaben, sodium paraben, sodium phenolsulfonate, sodium phenoxide, sodium o-phenylphenate, sodium propionate, sodium propylparaben, sodium sorbate, sorbic acid, triethanolamine sorbate, thianthol, triclocarban, triclosan, and undecylenoyl PEG-5 paraben.
27. A method for treating aging skin comprising contacting the skin with an effective amount of a composition of claim 1 .
28. A method for treating wounds comprising contacting the wound with an effective amount a composition of claim 1 .
29. A method for treating hyperpigmentation of skin comprising contacting the skin with an effective amount a composition of claim 1 .
30. A method for cosmetic treatment of skin, comprising contacting skin with an effective amount of the composition of claim 1 .
31. The method of claim 30 wherein the cosmetic treatment of skin is smoothening the skin, reducing hyperpigmentation of the skin, reducing wrinkles in the skin, reducing evidence of photodamage of the skin, or reducing the signs of aging in the skin.